EPISODE · Dec 2, 2013 · 9 MIN
Increasing Cytarabine Dose in AML Induction Improves Outcomes in Younger Patients
from Journal of Clinical Oncology (JCO) Podcast
This podcast describes the recent experience of high dose cytarabine induction in patients with acute myeloid leukemia (AML), as reported in the EORTCGIMEMA AML-12 trial. The podcast includes a summary of the trial and discussion of the implications of the finding that high dose cytarabine induction improves outcomes in younger patients with AML.
NOW PLAYING
Increasing Cytarabine Dose in AML Induction Improves Outcomes in Younger Patients
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m